BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8853770)

  • 21. Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study).
    Di Mario F; Battaglia F; Dal Bò N; Leandro G; Benedetti E; Bottona E; Caroli A; Costan-Biedo F; De Bastiani R; Germanà B; Andrea Grassi S; Madia D; Marcon V; Marin R; Monica F; Olivieri P; Orzes N; Pilotto A; Ronzani G; Saggioro A; Tafner G
    Dig Liver Dis; 2000 Mar; 32(2):108-15. PubMed ID: 10975783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up.
    Archimandritis A; Balatsos V; Delis V; Mentis A; Kastanas K; Scandalis N
    J Clin Gastroenterol; 1995 Jan; 20(1):12-6. PubMed ID: 7884169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori eradication as a surrogate marker for the reduction of duodenal ulcer recurrence.
    Neil GA; Suchower LJ; Johnson E; Ronca PD; Skoglund ML
    Aliment Pharmacol Ther; 1998 Jul; 12(7):619-33. PubMed ID: 9701525
    [TBL] [Abstract]